Analytical Reports on HEALTHSOUTH Corp. and DaVita Inc. - Specialized Health Services to Be Helped by Better Reimbursement Ra...
August 25 2011 - 8:36AM
Marketwired
www.SignalWatcher.com provides members with proprietary analysis of
over 10,000 stocks which is updated every day. Today, members can
receive their complimentary stock analysis on
HEALTHSOUTH Corp. (NYSE: HLS) and
DaVita Inc. (NYSE: DVA). Sign up now on
www.SignalWatcher.com to get your free reports on these stocks.
Specialized health care providers should benefit from the U.S.
government's announcement that the rate of Medicare reimbursement
payments will increase in 2012.
www.SignalWatcher.com brings investors free classic analysis on
HEALTHSOUTH Corp., DaVita Inc. and other companies within the
Specialized Health Services industry. This type of analysis is only
a fragment of the information members have available to them. To
learn more we encourage investors to sign up at
http://signalwatcher.com/EmailSignup.php.
The Centers for Medicare and Medicaid Services increased payment
rates by 1% and expects payments to acute-care hospitals to surge
by $1.13 billion in 2012. The news of higher reimbursement rates is
positive, but concerns of further budget cuts still remain for the
health sector as a whole.
Both HEALTHSOUTH Corp. and DaVita Inc. should benefit from the
increased reimbursement rates. Roughly 87% of DaVita's patients are
funded by Medicaid or Medicare. www.SignalWatcher.com gives traders
a unique insight about HEALTHSOUTH Corp. and
DaVita Inc. by registering now at
http://signalwatcher.com/HLS/August252011.php or
http://signalwatcher.com/DVA/August252011.php.
Despite the positive change, healthcare stocks saw a lot of
selling action in the beginning of the month, as investors feared
the effects that the Budget Control Act would have. The
ramifications for the health industry do not appear to be as far
reaching as once thought and investor confidence will likely return
as the actual effects of the bill are realized.
About Signal Watch
Signal Watch's #1 goal is to help customers successfully engage
the markets. For over 20 years, we have been developing the most
powerful trading software available anywhere. But the software is
only part of our mission. We also provide education and customer
support designed to enable our customers to take control of their
financial future.
Read our disclaimer by clicking on the following link
http://www.signalwatch.com/disclaimers.aspx
For More Information Contact: Eric Avalos Marketing
Advisor info@signalwatcher.com
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024